Cargando…

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis

BACKGROUND/AIMS: To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active rheumatoid arthritis (RA) refractory to conventional disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baek, Han Joo, Lim, Mie Jin, Park, Won, Park, Sung Hwan, Shim, Seung-Cheol, Yoo, Dae-Hyun, Kim, Hyun Ah, Lee, Soo Kon, Lee, Yun Jong, Park, Young Eun, Cha, Hoon-Suk, Song, Yeong-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610180/ https://www.ncbi.nlm.nih.gov/pubmed/29334721 http://dx.doi.org/10.3904/kjim.2017.159

Ejemplares similares

Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients
por: Lee, Sang Jin, et al.
Publicado: (2015)

Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
por: Lee, Sang Jin, et al.
Publicado: (2017)

Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
por: Song, Jason Jungsik, et al.
Publicado: (2018)

A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate Treatment
por: Kim, Jinhyun, et al.
Publicado: (2013)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
por: Shin, Kichul, et al.
Publicado: (2022)

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis
por: Lee, Joo-Hyun, et al.
Publicado: (2016)

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
por: Park, Jun Won, et al.
Publicado: (2022)

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
por: Kang, Young Mo, et al.
Publicado: (2018)

Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study
por: Choi, In Ah, et al.
Publicado: (2020)

Rheumatoid Factor is a Marker of Disease Severity in Korean Rheumatoid Arthritis
por: Shin, Yoo-Seob, et al.
Publicado: (2005)

Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
por: Yeo, Jina, et al.
Publicado: (2022)

Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey
por: Jeong, Hyemin, et al.
Publicado: (2017)

Diagnostic Performances of Anti-Cyclic Citrullinated Peptides Antibody and Antifilaggrin Antibody in Korean Patients with Rheumatoid Arthritis
por: Choi, Suk Woo, et al.
Publicado: (2005)

Prevalence of rheumatoid arthritis in relation to serum cadmium concentrations: cross-sectional study using Korean National Health and Nutrition Examination Survey (KNHANES) data
por: Joo, Sang Hyun, et al.
Publicado: (2019)

Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey
por: Jeong, Hyemin, et al.
Publicado: (2017)

Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults
por: Kim, Jin-Hee, et al.
Publicado: (2018)

Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial
por: Choi, In Ah, et al.
Publicado: (2014)

Injectable Gold-Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
por: Uhm, Wan-Sik, et al.
Publicado: (2000)

Mortality in Korean Patients With Rheumatoid Arthritis
por: Lee, Yeon-Kyung, et al.
Publicado: (2021)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Association of sleep duration with rheumatoid arthritis in Korean adults: analysis of seven years of aggregated data from the Korea National Health and Nutrition Examination Survey (KNHANES)
por: Kim, Jae-Hyun, et al.
Publicado: (2016)

Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis
por: Kwon, Young-Chang, et al.
Publicado: (2020)

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
por: Park, Min-Chan, et al.
Publicado: (2019)

Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea
por: Choi, In Ah, et al.
Publicado: (2016)

Vitamin D status and its associations with rheumatoid arthritis in Korean women: the Korean National Health and Nutrition Examination Survey 2008–2014
por: Lee, Taeck-Hyun, et al.
Publicado: (2016)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus
por: Park, Eun-Young, et al.
Publicado: (2018)

Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?
por: Lee, Seung-Geun, et al.
Publicado: (2013)

Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis
por: Lee, Eun Ha, et al.
Publicado: (2022)

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis
por: Na, Hyun Sik, et al.
Publicado: (2020)

The Risk of Osteoporotic Fractures According to the FRAX Model in Korean Patients with Rheumatoid Arthritis
por: Lee, Jae Ho, et al.
Publicado: (2014)

Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice
por: Ahn, Soo Min, et al.
Publicado: (2022)

Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
por: Song, Yeo-Jin, et al.
Publicado: (2023)

Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience
por: Ahn, Sung Soo, et al.
Publicado: (2018)

Interleukin-34-regulated T-cell responses in rheumatoid arthritis
por: Park, Hye Eun, et al.
Publicado: (2022)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
por: Yilmaz, Sedat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4198houfmse4qmibbjg2k1gh9o